Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prediction of interferon-alpha therapeutic effect by sequence variation of the HCV hypervariable region 1.

Yonsei medical journal - 1 Oct 1999

Yeh B I, Kim H W, Kim H S, Lee J Y, Lee K H, Lee K M, Kim J S, Han K H

Abstract excerpt

Interferon-alpha (IFN-alpha) has been used to treat hepatitis C virus (HCV)-induced hepatitis, but it has been effective in only about half of the treated patients, with recurrence appearing in the other half. As a consequence of the possible complications associated with IFN-alpha and the high cost of treatment, it has become extremely important to select the proper patients for IFN-alpha treatment. In our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Amino Acid Sequence
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Interferon-alpha

Share to Molecular Sequence Data

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 10565252
DOI: 10.3349/ymj.1999.40.5.430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prediction of interferon-alpha therapeutic effect by sequence variation of the HCV hypervariable region 1.PMID 10565252Read ↗

Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.Semantic proximity Read ↗

Prediction of effect of interferon on chronic hepatitis C.Semantic proximity Read ↗

Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome.Semantic proximity Read ↗

The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.Semantic proximity Read ↗

Predictive factors of a response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C.Semantic proximity Read ↗

Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment.Semantic proximity Read ↗

Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.Semantic proximity Read ↗

Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.Semantic proximity Read ↗

High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.Semantic proximity Read ↗

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.Semantic proximity Read ↗

Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.